Compare MPWR & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPWR | IDXX |
|---|---|---|
| Founded | 1997 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.9B | 55.0B |
| IPO Year | 2004 | 1991 |
| Metric | MPWR | IDXX |
|---|---|---|
| Price | $952.68 | $711.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 10 |
| Target Price | ★ $1,006.88 | $700.50 |
| AVG Volume (30 Days) | ★ 766.9K | 485.5K |
| Earning Date | 02-05-2026 | 02-02-2026 |
| Dividend Yield | ★ 0.62% | N/A |
| EPS Growth | ★ 343.79 | 21.65 |
| EPS | ★ 39.37 | 12.60 |
| Revenue | $2,660,969,000.00 | ★ $4,167,411,000.00 |
| Revenue This Year | $28.54 | $12.15 |
| Revenue Next Year | $16.99 | $8.72 |
| P/E Ratio | ★ $25.54 | $56.09 |
| Revenue Growth | ★ 30.48 | 8.39 |
| 52 Week Low | $438.86 | $356.14 |
| 52 Week High | $1,123.38 | $769.98 |
| Indicator | MPWR | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 51.52 | 57.16 |
| Support Level | $906.33 | $661.89 |
| Resistance Level | $1,009.59 | $690.05 |
| Average True Range (ATR) | 29.03 | 15.15 |
| MACD | 3.63 | 0.94 |
| Stochastic Oscillator | 47.46 | 77.37 |
Monolithic Power Systems is an analog and mixed-signal chipmaker specializing in power management solutions. Its mission is to reduce total energy consumption in end systems. It serves the computing, automotive, industrial, communications, and consumer end markets. MPS uses a fabless manufacturing model, partnering with third-party chip foundries to host its proprietary BCD process technology.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.